EFFECT OF 3'-AZIDO-2',3'-DIDEOXYTHYMIDINE (AZT) AND NEUTRALIZING ANTIBODY ON HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-INDUCED CYTOPATHIC EFFECTS - IMPLICATION OF GIANT-CELL FORMATION FOR THE SPREAD OF VIRUS INVIVO

被引：34
作者：
NAKASHIMA, H
TOCHIKURA, T
KOBAYASHI, N
MATSUDA, A
UEDA, T
YAMAMOTO, N
机构：
[1] YAMAGUCHI UNIV,SCH MED,DEPT VIROL & PARASITOL,UBE,YAMAGUCHI 755,JAPAN
[2] HOKKAIDO UNIV,FAC PHARMACEUT SCI,SAPPORO,HOKKAIDO 060,JAPAN
来源：
VIROLOGY | 1987年 / 159卷 / 01期
关键词：
D O I：
10.1016/0042-6822(87)90362-X
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：169 / 173
页数：5
相关论文
共 19 条
[1]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[2]   A PATHOGENIC RETROVIRUS (HTLV-III) LINKED TO AIDS [J].
BRODER, S ;
GALLO, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (20) :1292-1297
[3]   PREVALENCE OF ANTIBODIES TO LYMPHADENOPATHY-ASSOCIATED RETROVIRUS IN AFRICAN PATIENTS WITH AIDS [J].
BRUNVEZINET, F ;
ROUZIOUX, C ;
MONTAGNIER, L ;
CHAMARET, S ;
GRUEST, J ;
BARRESINOUSSI, F ;
GEROLDI, D ;
CHERMANN, JC ;
MCCORMICK, J ;
MITCHELL, S ;
PIOT, P ;
TAELMAN, H ;
MIRLANGU, KB ;
WOBIN, O ;
MBENDI, N ;
MAZEBO, P ;
KALAMBAYI, K ;
BRIDTS, C ;
DESMYTER, J ;
FEINSOD, FM ;
QUINN, TC .
SCIENCE, 1984, 226 (4673) :453-456
[4]   THE CD4 (T4) ANTIGEN IS AN ESSENTIAL COMPONENT OF THE RECEPTOR FOR THE AIDS RETROVIRUS [J].
DALGLEISH, AG ;
BEVERLEY, PCL ;
CLAPHAM, PR ;
CRAWFORD, DH ;
GREAVES, MF ;
WEISS, RA .
NATURE, 1984, 312 (5996) :763-767
[5]   QUANTITATIVE CHANGES IN T-HELPER OR T-SUPPRESSOR CYTO-TOXIC LYMPHOCYTE SUBSETS THAT DISTINGUISH ACQUIRED IMMUNE-DEFICIENCY SYNDROME FROM OTHER IMMUNE SUBSET DISORDERS [J].
FAHEY, JL ;
PRINCE, H ;
WEAVER, M ;
GROOPMAN, J ;
VISSCHER, B ;
SCHWARTZ, K ;
DETELS, R .
AMERICAN JOURNAL OF MEDICINE, 1984, 76 (01) :95-100
[6]   INFECTION OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I (HTLV-I)-BEARING MT-4 CELLS WITH HTLV-III (AIDS VIRUS) - CHRONOLOGICAL STUDIES OF EARLY EVENTS [J].
HARADA, S ;
KOYANAGI, Y ;
YAMAMOTO, N .
VIROLOGY, 1985, 146 (02) :272-281
[7]   INFECTION OF HTLV-III/LAV IN HTLV-I-CARRYING CELLS MT-2 AND MT-4 AND APPLICATION IN A PLAQUE-ASSAY [J].
HARADA, S ;
KOYANAGI, Y ;
YAMAMOTO, N .
SCIENCE, 1985, 229 (4713) :563-566
[8]   SEROLOGICAL DIFFERENCES BETWEEN HUMAN T-LYMPHOTROPIC VIRUS TYPE-I (HTLV-I) AND HTLV-III LAV [J].
HARADA, S ;
PURTILO, DT ;
KOYANAGI, Y ;
YAMAMOTO, N .
MICROBIOLOGY AND IMMUNOLOGY, 1986, 30 (06) :533-544
[9]   ESTABLISHMENT OF A HIGH PRODUCTION SYSTEM FOR AIDS RETROVIRUSES WITH A HUMAN T-LEUKEMIC CELL-LINE MOLT-4 [J].
KOYANAGI, Y ;
HARADA, S ;
YAMAMOTO, N .
CANCER LETTERS, 1986, 30 (03) :299-310
[10]   ISOLATION OF LYMPHOCYTOPATHIC RETROVIRUSES FROM SAN-FRANCISCO PATIENTS WITH AIDS [J].
LEVY, JA ;
HOFFMAN, AD ;
KRAMER, SM ;
LANDIS, JA ;
SHIMABUKURO, JM .
SCIENCE, 1984, 225 (4664) :840-842
12